Comprehensive Liquid Biopsy Approaches for the Clinical Management of Lung Cancer Using Multiple Biological Matrices

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Lung cancer is a leading cause of cancer mortality worldwide.
• Non-small cell lung cancer (NSCLC) comprises 85-90% of all lung cancer cases.
• Liquid biopsy provides a non-invasive method to analyze circulating tumor DNA.

Purpose of the Study:

• To highlight the significance of prognostic, predictive, and diagnostic biomarkers in lung cancer.
• To emphasize the role of liquid biopsies in detecting these biomarkers.
• To showcase the integration of bioinformatics for personalized lung cancer treatment.

Main Methods:

• Analysis of tumor-derived material in body fluids via liquid biopsy.
• Utilizing bioinformatics tools for high-dimensional omics data analysis.
• Detection of biomarkers for early diagnosis, prognosis, and therapy response prediction.

Main Results:

• Liquid biopsies enable genomic profiling without invasive tissue sampling.
• Biomarkers for lung cancer detection, prognosis, and treatment prediction can be identified.
• Bioinformatics transforms complex omics data into actionable clinical insights.

Conclusions:

• Liquid biopsies are crucial for identifying lung cancer biomarkers across subtypes.
• Integrating bioinformatics facilitates the development of personalized molecular profiles.
• This approach supports individualized treatment strategies for lung cancer patients.